These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38505782)

  • 21. Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study.
    Hajiaghamohammadi AA; Ziaee A; Oveisi S; Masroor H
    Hepat Mon; 2012 Aug; 12(8):e6099. PubMed ID: 23087748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 23. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Del Bo' C; Perna S; Allehdan S; Rafique A; Saad S; AlGhareeb F; Rondanelli M; Tayyem RF; Marino M; Martini D; Riso P
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials.
    Zhou J; Chen Y; Yu J; Li T; Lu Z; Chen Y; Zhang X; Ye F
    Medicine (Baltimore); 2021 Mar; 100(12):e24884. PubMed ID: 33761646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Liu N; Yang J; Ma W; Li C; An L; Zhang X; Zou Q
    J Ethnopharmacol; 2022 Apr; 288():114999. PubMed ID: 35051605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Houttu V; Csader S; Nieuwdorp M; Holleboom AG; Schwab U
    Front Nutr; 2021; 8():716783. PubMed ID: 34368214
    [No Abstract]   [Full Text] [Related]  

  • 28. Silymarin in non alcoholic fatty liver disease.
    Cacciapuoti F; Scognamiglio A; Palumbo R; Forte R; Cacciapuoti F
    World J Hepatol; 2013 Mar; 5(3):109-13. PubMed ID: 23556042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
    Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
    Front Nutr; 2022; 9():880014. PubMed ID: 35669067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials.
    Mohtashaminia F; Amini MR; Sheikhhossein F; Djafarian K; Shab-Bidar S
    Clin Nutr ESPEN; 2022 Jun; 49():181-186. PubMed ID: 35623810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.
    Qiu J; Kuang M; Yang R; Yu C; He S; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1239398. PubMed ID: 37727457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.
    Xiong Y; Peng Q; Cao C; Xu Z; Zhang B
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
    Wang Y; Wang Y; Sun J
    Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of orlistat in obese patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
    Mahmoud A; Mohamed I; Abuelazm M; Ahmed AAS; Saeed A; Elshinawy M; Almaadawy O; Abdelazeem B
    Proc (Bayl Univ Med Cent); 2024; 37(4):603-612. PubMed ID: 38910819
    [No Abstract]   [Full Text] [Related]  

  • 36. Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysis.
    Pastori D; Pani A; Di Rocco A; Menichelli D; Gazzaniga G; Farcomeni A; D'Erasmo L; Angelico F; Del Ben M; Baratta F
    Br J Clin Pharmacol; 2022 Feb; 88(2):441-451. PubMed ID: 34133035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery.
    Malucelli M; Strobel R; Ivantes C; Sakamoto D; Luís Duarte M; Lucia Alves Pedroso M
    Arch Endocrinol Metab; 2023 Nov; 68():e220138. PubMed ID: 37948562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
    Fogacci F; Grassi D; Rizzo M; Cicero AFG
    Phytother Res; 2019 Apr; 33(4):862-870. PubMed ID: 30632209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials.
    Abuelazm MT; Mohamed I; Naeem A; Khlidj Y; Tanashat M; Katamesh BE; Abusuilik H; Altobaishat O; Abdelnabi M; Abdelazeem B
    Eur J Gastroenterol Hepatol; 2024 Apr; 36(4):371-381. PubMed ID: 38407890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.